| 3232 |
2229: Acrolein accumulation |
1603: Chronic kidney disease |
Jun 4, 2024 |
Jun 4, 2024 |
1 AOP
|
| 1442 |
1340: Activate, calmodulin |
1341: Increase, myosin light chain phosphorylation |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 1464 |
1359: Activate, GABA-A receptor |
1322: Increased, intracellular chloride (Cl-) |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 1476 |
1379: Activate, leukocyte |
1385: Activated, gastric ulcer formation |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1475 |
1380: Activate, mucosal defense |
1367: Inhibit, gastric ulcer formation |
Apr 17, 2017 |
Apr 17, 2017 |
1 AOP
|
| 1488 |
1383: Activate, phospholipase |
1382: Decrease, surfactant |
Apr 17, 2017 |
Apr 17, 2017 |
2 AOPs
|
| 1439 |
1337: Activate, PLC |
1338: Increase, inositol triphosphate |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 1461 |
1360: Activate, presynaptic neuron 2 |
1361: Increase, GABA |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 3015 |
2173: Activated AKT/ERK/PI3K pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3024 |
2173: Activated AKT/ERK/PI3K pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3010 |
2170: Activated ANG/Tie2 pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3020 |
2170: Activated ANG/Tie2 pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3012 |
2171: Activated BMP/TGF-beta pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3021 |
2171: Activated BMP/TGF-beta pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 3013 |
2172: Activated Wnt/Frizzled pathway |
2161: Increase, Vascular disrupting effects |
Aug 21, 2023 |
Aug 21, 2023 |
None
|
| 3022 |
2172: Activated Wnt/Frizzled pathway |
1928: increased,Vascular endothelial dysfunction |
Aug 21, 2023 |
Aug 21, 2023 |
1 AOP
|
| 1559 |
1421: Activated, LXR |
1422: Reduced, PPARalpha |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1458 |
1355: Activated, membrane depolarization |
1362: Increased, hippocampal hyperdepolarization |
Apr 14, 2017 |
Apr 14, 2017 |
3 AOPs
|
| 1454 |
1351: Activated, NMDA receptor |
1321: Increased, intracellular sodium (Na+) |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 1452 |
1349: Activated, presynaptic neuron 1 |
1350: Increased, glutamate |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 3086 |
1349: Activated, presynaptic neuron 1 |
1018: Activation, Glutamate-gated chloride channels |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 3088 |
1349: Activated, presynaptic neuron 1 |
1177: Decreased, Ionotropic GABA receptor chloride channel conductance |
Oct 17, 2023 |
Oct 17, 2023 |
1 AOP
|
| 1457 |
1352: Activated, voltage-gated sodium channel |
1355: Activated, membrane depolarization |
Apr 14, 2017 |
Apr 14, 2017 |
2 AOPs
|
| 2996 |
2169: Activation of Angiogenic cytokines |
1928: increased,Vascular endothelial dysfunction |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|
| 2995 |
2168: Activation of angiopoietin like protein 4 |
1928: increased,Vascular endothelial dysfunction |
Aug 20, 2023 |
Aug 20, 2023 |
1 AOP
|